My watch list  

10 Current news from taiwan


You can refine your search further. Select from the filter options on the left to narrow down your results.

Cytena Founds Subsidiary in Taiwan


Cytena is continuing its growth with the establishment of its subsidiary Cytena Bioprocess Solutions in Taiwan. Cytena Bioprocess Solutions is developing an innovative technology, which enables considerable reductions in time and increases in efficiency for cell line development. "With the new ...


DKSH extends partnership with LAUDA to Singapore and Taiwan


DKSH, the leading Market Expansion Services provider with a focus on Asia, and LAUDA, a global leader in manufacturing thermal-controlling instruments, have signed a distributor agreement for Singapore and Taiwan for the product line of constant temperature equipment. DKSH Business Unit ...


A strategy for combating drug-resistant cancers


Many cancer therapies function by activating proteins like Caspase-3 (CASP3) that promote cell death. Several forms of cancer develop resistance to these drugs by down regulating CASP3 through an unknown mechanism. In the absence of CASP3, tumor cells produce another cell death promoting protein ...


Citrus peel could fight prostate cancer


Scientists in Taiwan and Japan have tested a citrus peel extract called Gold Lotion (GL) (previously shown by the authors to protect against colon tumours) and demonstrated that treatment with GL by both intraperitoneal injection and oral administration dramatically reduced both the weights and ...


Gold nanoparticles target HIV


Gold nanoparticles functionalised with aptamers have been found to be highly effective inhibitors for human immunodeficiency virus type 1 reverse transcriptase. The nanoparticles particles have been shown to reduce the ability of the HIV virus to reproduce and infect new cells. The scientists ...


Abnova and Clearbridge BioMedics Accelerate Circulating Tumor Cell System into the Research and In Vitro Diagnostic Markets


Abnova Corporation and Clearbridge BioMedics announced a collaboration to jointly develop a platform that provides a next generation, non-invasive “liquid biopsy” for cancer screening, staging, treatment, and monitoring. Through this collaboration, Abnova will leverage upon Clearbridge BioMedics’ ...


MediGene Signs Veregen Commercialization Agreement with SynCore Bio in Taiwan


MediGene AG has signed an exclusive license and supply agreement with SynCore Bio, a subsidiary of the Sinphar Group, for the commercialization and marketing of Veregen® ointment in Taiwan for the treatment of genital warts. MediGene will supply Sinphar with API, Sinphar will produce the drug in ...


to-BBB starts manufacturing collaboration with TTY Biopharm for brain cancer treatment


TTY Biopharm will become a co-development partner of to-BBB for the manufacturing of brain-targeted doxorubicin liposomes. These liposomes are essential for the clinical development of to-BBB’s lead product for the treatment of brain cancer. Werner Gladdines, Head of Clinical Operations at ...


Olink Bioscience and Abnova signs co-marketing agreement to promote unique target-specific assays for cell signaling studies


Olink Bioscience and Abnova Corporation announced a co-development and co-marketing agreement. This collaboration will address the unmet need for high-performance assays for studies of protein phosphorylation and protein interactions by combining Abnova´s growing collection of antibodies with the ...


Research and Markets: Company and Industry Analysis of the US $ 14.9 Billion Asia-Pacific Biotechnology Market


Research and Markets has announced the addition of the "Asia-Pacific Biotechnology Sectors : A Company and Industry Analysis" report to their offering. This report updates the previous Asia-Pacific biotechnology report, focusing on the markets in Australia, China and Hong Kong, India, Japan, ...


Page 1 From 1
Subscribe to e-mail updates relating to your search

You will receive via e-mail the latest search results matching your search criteria. This service is free of charge and can be cancelled at any time.

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE